Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Solid Tumor × niraparib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Ovarian Neoplasms 34 Prostatic Neoplasms 11 Breast Neoplasms 9 Fallopian Tube Neoplasms 7 Pancreatic Neoplasms 6 Glioblastoma 6 Endometrial Neoplasms 5 Neoplasms 4 Neoplasm Metastasis 4 Glioma 4 Small Cell Lung Carcinoma 3 Lung Neoplasms 3 Cholangiocarcinoma 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Recurrence 2 Mesothelioma, Malignant 2 Mesothelioma 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Ovarian Epithelial 2 Brain Neoplasms 2 Biliary Tract Neoplasms 2 Uveal Melanoma 1 Uterine Neoplasms 1 Urothelial Cancer 1 Unilateral Breast Neoplasms 1

Interventions

Fluorodeoxyglucose F18 7 Irinotecan 4 Fluorouracil 4 Bevacizumab 4 pembrolizumab 3 olaparib 3 Radiosurgery 3 Cyclophosphamide 3 Cisplatin 3 Capecitabine 3 vistusertib 2 toripalimab 2 tislelizumab 2 spartalizumab 2 fludarabine 2 atezolizumab 2 apatinib 2 Temozolomide 2 Radiotherapy 2 Proton Therapy 2 Paclitaxel 2 Leucovorin 2 Letrozole 2 Hydroxychloroquine 2 Everolimus 2 Drug Therapy 2 Docetaxel 2 tumor-cells apoptosis factor, human 1 trifluridine tipiracil drug combination 1 trametinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04185831 2024-08-22

MEGALiT

Uppsala University Hospital

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡